Allan Philp

Why 30 mg Twice Daily Fails: Anti-Factor Xa Monitoring and the Persistent Dosing Gap in High-Risk Trauma Patients

Introduction Contemporary trauma guidelines support higher initial enoxaparin dosing for adult trauma patients, as standard dosing (30 mg twice daily [BID]) frequently fails to achieve target anticoagulant activity. While anti-factor Xa (anti-Xa) monitoring guides dose adjustment...